Page last updated: 2024-10-22

amodiaquine and Dermatitis Medicamentosa

amodiaquine has been researched along with Dermatitis Medicamentosa in 2 studies

Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.

Research Excerpts

ExcerptRelevanceReference
" Dosage data indicated that fatalities had taken higher doses and continued prophylaxis after onset of symptoms."1.28Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. ( Phillips-Howard, PA; West, LJ, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SCHLOEDER, FX1
Phillips-Howard, PA1
West, LJ1

Other Studies

2 other studies available for amodiaquine and Dermatitis Medicamentosa

ArticleYear
Unusual toxic reaction to amodiaquine (camoquin). Report of a case.
    Archives of dermatology, 1961, Volume: 84

    Topics: Amodiaquine; Antimalarials; Drug Eruptions; Humans; Medical Records; Postoperative Complications

1961
Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.
    Journal of the Royal Society of Medicine, 1990, Volume: 83, Issue:2

    Topics: Adolescent; Adult; Amodiaquine; Antimalarials; Chemical and Drug Induced Liver Injury; Child; Child,

1990